Related Experiment Video

Updated: Jul 30, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Prominence of withdrawal symptoms in polydrug-exposed infants

K D'Apolito1, J T Hepworth

  • 1Vanderbilt University School of Nursing, Nashville, Tennessee, USA.

The Journal of Perinatal & Neonatal Nursing
|April 5, 2002
PubMed

Insights

Prenatal exposure to multiple drugs, including alcohol, opiates, stimulants, and sedatives, causes significant infant withdrawal. This study identifies the most prominent signs and symptoms in these vulnerable newborns.

Area of Science:

  • Perinatal Health
  • Neonatal Abstinence Syndrome
  • Polydrug Exposure

Background:

  • Drug use during pregnancy is a significant perinatal health concern.
  • 200,000 infants annually are born to mothers using illegal drugs.
  • Limited data exists on withdrawal from polydrug exposure compared to single substances.

Purpose of the Study:

  • To identify the most prominent signs and symptoms of withdrawal in infants exposed to polydrugs in utero.
  • To provide new information on neonatal abstinence syndrome (NAS) from combined substance exposure.

Main Methods:

  • The study analyzed infants exposed prenatally to combinations of alcohol, opiates, stimulants, and sedatives.
  • Detailed observation and documentation of withdrawal signs and symptoms were conducted.

Main Results:

  • The study highlights the most prominent physiological and neurobehavioral withdrawal signs observed in infants with polydrug exposure.
  • Specific patterns of withdrawal associated with combinations of substances were identified.

Conclusions:

  • Understanding prominent withdrawal symptoms in polydrug-exposed infants is crucial for effective neonatal care.
  • Further research is needed to fully elucidate the complexities of NAS from polydrug exposure.

More Related Videos

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...